Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Quinolinone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN119823040A enables efficient one-step production of high-purity dihydroisoquinolinone derivatives through palladium catalysis with TFBen CO source.
Patent CN112125843A enables metal-free synthesis of 3-hydroxymethyl dihydroquinolinone with mild conditions, enhancing supply chain reliability and cost efficiency for pharmaceutical intermediates manufacturing.
Patent CN118754854A enables efficient one-step synthesis of bioactive quinolinones through palladium-catalyzed tandem reactions, enhancing supply chain reliability while reducing manufacturing complexity for pharmaceutical intermediates.
Patent CN113045489B enables efficient synthesis of quinolinone intermediates with simplified process flow and enhanced supply chain reliability for global pharmaceutical manufacturers.
Novel palladium-catalyzed method for 3-arylquinolinone synthesis with simplified process and enhanced supply chain reliability for pharmaceutical manufacturing.
Patent CN116496215A enables efficient synthesis of pharmaceutical intermediates through palladium-catalyzed cascade reactions offering enhanced scalability and cost reduction in drug manufacturing.
Novel palladium-catalyzed tandem reaction enables high-efficiency synthesis of polycyclic quinolinones with simplified post-treatment processes enhancing supply chain reliability and cost reduction in pharmaceutical manufacturing.
Patent CN116496215B introduces a novel palladium-catalyzed method for polycyclic quinolinone synthesis with simplified process flow and enhanced supply chain reliability.
Patent CN115403520B enables efficient quinolinone production via palladium-catalyzed carbonylation using benzyl sulfonyl chloride for cost-effective pharmaceutical intermediate manufacturing.
Novel one-pot rhodium-catalyzed tandem reaction enables scalable furanoisoquinolinone production with enhanced purity profiles and simplified manufacturing complexity for agrochemical applications.
Patent CN113045489B introduces a novel palladium-catalyzed aminocarbonylation method for 3-arylquinolinone derivatives, offering simplified process and enhanced supply chain reliability for pharmaceutical manufacturing.
Patent CN113045489B introduces a streamlined palladium-catalyzed method for high-purity quinolinone derivatives with simplified process flow and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN116496215B introduces a novel palladium-catalyzed synthesis method for polycyclic quinolinone intermediates, enabling enhanced scalability and reduced manufacturing costs for pharmaceutical applications.
Economical Mn(OAc)3-catalyzed process delivers high-yield heterocyclic derivatives with broad substrate scope, enhancing supply chain reliability and reducing manufacturing costs for pharmaceutical applications.
Patent CN102382051A enables high-purity isoquinolinone intermediates with streamlined manufacturing, reducing lead time and cost for pharmaceutical supply chains.
Novel palladium-catalyzed synthesis enables high-purity nitrogen-containing tricyclic quinolinone with simplified process, reducing lead time and manufacturing costs for pharmaceutical intermediates.
Solve multi-step synthesis challenges for polycyclic quinolinone derivatives with 50-70% yields. Reduce costs and supply chain risks with scalable, high-purity production.
Discover catalyst-free, ethanol-based synthesis of 3,4-dihydro-3-(2-hydroxybenzoyl)-2(1H)-quinolinone with 70-80% yield. Reduce costs and supply chain risks for API manufacturing.
Solve supply chain risks with this Pd-catalyzed quinolinone synthesis. 99%+ purity, 24-48h reaction time, and cheap raw materials. Scale to 100 MT/yr with NINGBO INNO PHARMCHEM.
Discover how metal-free, photo-catalyzed synthesis of perfluoroalkyl benzimidazoloisoquinolinones reduces costs and supply chain risks for pharmaceutical intermediates. Contact us for custom synthesis.